Skip to main content
. 2024 Feb 20;25:7. doi: 10.1186/s10195-024-00751-9

Table 2.

Baseline comparability (IKDC)

Endpoint All-epiphyseal (N = 918) Trans-epiphyseal (N = 575) P
Mean follow-up (months) 51.4 ± 37.9 40.6 ± 20.8 0.2
Mean age 13.2 ± 1.6 12.1 ± 1.7 0.2
Female (%) 40% (369 of 917) 21% (121 of 572) 0.05
IKDC (mean) 42.7 ± 3.8 50.4 ± 7.0 0.2
Tegner (mean) 5.5 ± 1.9 7.3 ± 0.6 0.3